Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ieva Saulite

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Swiss Medical Weekly|September 8, 2021
Management of dupilumab-associated ocular surface diseases in atopic dermatitis patientsYan Guex-Crosier, Julie Di-Lucca, Peter Häusermann, et al.
The Journal of Dermatological Treatment|February 12, 2016
Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndromeAstrid Sönnichsen, Ieva Saulite, Johanna Mangana, et al.
Journal of the American Academy of Dermatology|July 16, 2017
Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort studyAaron R Mangold, Agnieszka K Thompson, Mark D Davis, et al.
Acta Dermato-Venereologica|November 3, 2015
Expression of CD164 on Malignant T cells in Sézary SyndromeEmmanuella Guenova, Desislava Ignatova, Yun-Tsan Chang, et al.
Dermatology (Basel, Switzerland)|February 14, 2022
Radiotherapy as a Treatment Option for Local Disease Control in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg TypeMara Zehnder, Boyko Amarov, André N Abrunhosa-Branquinho, et al.
Oncoimmunology|August 8, 2020
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferationIeva Saulite, Desislava Ignatova, Yun-Tsan Chang, et al.
The EMBO Journal|July 4, 2019
Proteomic identification of a marker signature for MAPKi resistance in melanomaVerena Paulitschke, Ossia Eichhoff, Christopher Gerner, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Swiss Medical Weekly|September 8, 2021
Management of dupilumab-associated ocular surface diseases in atopic dermatitis patientsYan Guex-Crosier, Julie Di-Lucca, Peter Häusermann, et al.
The Journal of Dermatological Treatment|February 12, 2016
Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndromeAstrid Sönnichsen, Ieva Saulite, Johanna Mangana, et al.
Journal of the American Academy of Dermatology|July 16, 2017
Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort studyAaron R Mangold, Agnieszka K Thompson, Mark D Davis, et al.
Acta Dermato-Venereologica|November 3, 2015
Expression of CD164 on Malignant T cells in Sézary SyndromeEmmanuella Guenova, Desislava Ignatova, Yun-Tsan Chang, et al.
Dermatology (Basel, Switzerland)|February 14, 2022
Radiotherapy as a Treatment Option for Local Disease Control in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg TypeMara Zehnder, Boyko Amarov, André N Abrunhosa-Branquinho, et al.
Oncoimmunology|August 8, 2020
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferationIeva Saulite, Desislava Ignatova, Yun-Tsan Chang, et al.
The EMBO Journal|July 4, 2019
Proteomic identification of a marker signature for MAPKi resistance in melanomaVerena Paulitschke, Ossia Eichhoff, Christopher Gerner, et al.
Pageof 2